Related Experiment Videos
[Effect of mouse p53 minigene on lung cancer cells with different 172 structures regulated by tetracycline]
1Department of Pathology, Health Science Center, Peking University, Beijing 100083, China.
Objective:
To investigate the effect of mouse 172 wild-type p53 (Arg), pseudo-wild-mutant-type p53 (Arg-->Leu) and mutant-type p53 (Arg-->His) induced by absence of tetracycline on the growth of PG cell line.
Methods:
Three variant types of p53 minigene were sub-cloned by gene recombination into an expression vector which was controlled by tetracycline. Through LipofectAMINE, the vectors were transfected into p53 defective PG (248CGG-->CTT) cells, and the transfectants were screened in the selecting medium containing puromycin. Tumor suppressing effects were studied by MTT absorption, flow cytometry and Western blotting.
Results:
Wild-type p53 and pseudo-wild-mutant-type p53 could lead cells to decrease their growth rates, arrest cell cycle and transactivation of p21(WAF1). Mutant-type p53 was defective in tumor suppression.
Conclusion:
Wild-type p53 and pseudo-wild-type p53 may inhibit cell growth and induce cell cycle arrest. Some p53 variants such as 172 Arg-->Leu can still retain the tumor suppression function of the wild-type.
Insights
Wild-type and pseudo-wild-type p53 variants inhibit cancer cell growth and arrest the cell cycle. Some p53 variants retain tumor suppression functions, offering potential therapeutic insights.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Context:
- The tumor suppressor protein p53 plays a critical role in preventing cancer.
- Mutations in p53 are common in human cancers, often leading to loss of function.
- Understanding the functional consequences of different p53 variants is crucial for developing targeted therapies.
Purpose:
- To investigate the impact of wild-type p53, a pseudo-wild-type mutant (Arg-->Leu), and a mutant-type p53 (Arg-->His) on the growth of the p53-defective PG cell line.
- To analyze the tumor suppressive effects of these p53 variants using MTT assays, flow cytometry, and Western blotting.
Summary:
- Wild-type p53 and the pseudo-wild-type p53 variant (Arg-->Leu) significantly reduced PG cell growth rates.
- Both wild-type and pseudo-wild-type p53 induced cell cycle arrest and transactivation of p21(WAF1).
- The mutant-type p53 (Arg-->His) exhibited defective tumor suppressor activity.
Impact:
- This study demonstrates that certain p53 variants, like 172 Arg-->Leu, can retain wild-type tumor suppression capabilities.
- Findings suggest that specific p53 mutations may not completely abolish tumor suppressor function, opening avenues for therapeutic strategies.
- The research contributes to a deeper understanding of p53 functional diversity in cancer biology.